Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12866)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2017 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Adhoute X, Pénaranda G, Raoul JL, Edeline J, Blanc JF, Pol B, Campanile M, Perrier H, Bayle O, Monnet O, Beaurain P, Muller C, Castellani P, Le Treut YP, Bronowicki JP, Bourlière M. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World J Gastroenterol 2017; 23(14): 2545-2555 [PMID: 28465639 DOI: 10.3748/wjg.v23.i14.2545] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i14/2545.htm |
| Number | Citing Articles |
| 1 |
David Thayer, Christopher Noda, Resmi Charalel, Abigail Mills, Randy Chang, Yu Tao, Olaguoke Akinwande. Survival comparison of hepatocellular carcinoma patients treated with radioembolization versus nonoperative/interventional treatment. Journal of Comparative Effectiveness Research 2018; 7(4): 343 doi: 10.2217/cer-2017-0064
|
| 2 |
Dashuai Yang, Mingqiang Zhu, Xiangyun Xiong, Yang Su, Fangrui Zhao, Yong Hu, Guo Zhang, Junpeng Pei, Youming Ding. Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.987603
|
| 3 |
Dirk Andreas Ridder, Mario Schindeldecker, Arndt Weinmann, Kristina Berndt, Lana Urbansky, Hagen Roland Witzel, Stefan Heinrich, Wilfried Roth, Beate Katharina Straub. Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma. Cancers 2021; 13(4): 744 doi: 10.3390/cancers13040744
|
| 4 |
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Journal of the Chinese Medical Association 2021; 84(6): 606 doi: 10.1097/JCMA.0000000000000530
|
| 5 |
Alonso Heriberto Ramírez-Sánchez, Iván Eliud Casanova-Sánchez, Sergio Esquivel-Torres, Alma Yrani Escobar-Ríos, Gustavo Martínez-Mier. Resultados de la ablación por radiofrecuencia en el tratamiento de carcinoma hepatocelular en Veracruz, México. Cirujano General 2021; 43(1): 23 doi: 10.35366/103910
|
| 6 |
Pedro Viveiros, Ahsun Riaz, Robert J. Lewandowski, Devalingam Mahalingam. Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC). Cancers 2019; 11(8): 1085 doi: 10.3390/cancers11081085
|
| 7 |
Amit G. Singal, Neehar D. Parikh, Nicole E. Rich, Binu V. John, Anjana Pillai. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 27 doi: 10.1007/978-3-030-21540-8_2
|
| 8 |
Sophia Heinrich, Martin Sprinzl, Irene Schmidtmann, Elena Heil, Sandra Koch, Carolin Czauderna, Bernd Heinrich, Laurence Philippe P Diggs, Marcus‐Alexander Wörns, Roman Kloeckner, Peter R Galle, Jens U Marquardt, Arndt Weinmann. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. United European Gastroenterology Journal 2020; 8(4): 444 doi: 10.1177/2050640620904524
|
| 9 |
Chia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, Cheng-Yuan Hsia, Praneeth Kudaravalli, Yun-Hsuan Lee, Yi-You Chiou, Ya-Ju Tsai, Yi-Hsiang Huang, Teh-Ia Huo. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4202-3
|
| 10 |
Xavier Adhoute, Edouard Larrey, Guillaume Pénaranda, Rodolphe Anty. ALBI‐based BCLC nomogram: A new or an additional prognostic tool?. Liver International 2020; 40(7): 1785 doi: 10.1111/liv.14431
|
| 11 |
Jiarui Yang, Shuguang Zhu, Juanjuan Yong, Long Xia, Xiangjun Qian, Jiawei Yang, Xueqiao Hu, Yuxuan Li, Chusi Wang, Wenguang Peng, Lei Zhang, Meihai Deng, Weidong Pan. A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.616976
|
| 12 |
María Pipa-Muñiz, Susana Sanmartino, Alicia Mesa, Carmen Álvarez-Navascués, Maria-Luisa González-Diéguez, Valle Cadahía, José-Eduardo Rodríguez, Florentino Vega, Manuel Rodríguez, Serafin-Marcos Costilla-García, María Varela. The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01307-x
|
| 13 |
Kazunari Tanaka, Kunihiko Tsuji, Takeshi Matsui, Jong‐Hon Kang, Yasuo Sakurai, Yoshihisa Kodama, Ryosuke Minami, Kiichi Watanabe, Akio Katanuma. Potential of PALBI‐T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease. JGH Open 2022; 6(1): 36 doi: 10.1002/jgh3.12705
|
| 14 |
V. A. Vishnevsky, Kh. A. Ayvazyan, R. Z. Ikramov, D. A. Ionkin, O. I. Zhavoronkova, Yu. A. Stepanova, A. B. Varava, Yu. A. Kovalenko, Yu. O. Zharikov, A. B. Goncharov, A. A. Olifir, A. Yu. Pakhomova, S. A. Bugaev, A. V. Zhao. Modern principles of hepatocellular carcinoma treatment. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 15 doi: 10.16931/1995-5464.2020215-26
|
| 15 |
Gauri Mishra, Ammar Majeed, Anouk Dev, Guy D. Eslick, David J. Pinato, Hirofumi Izumoto, Atsushi Hiraoka, Teh-Ia Huo, Po-Hong Liu, Philip J. Johnson, Stuart K. Roberts. Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Cancer 2023; 54(2): 420 doi: 10.1007/s12029-022-00832-0
|
| 16 |
Xiaowei Chen, Changhui Fu, Yaqin Wang, Qirun Wu, Xianwei Meng, Ke Xu. Mitochondria-targeting nanoparticles for enhanced microwave ablation of cancer. Nanoscale 2018; 10(33): 15677 doi: 10.1039/C8NR03927E
|
| 17 |
Bernhard Scheiner, Gregor Ulbrich, Mattias Mandorfer, Thomas Reiberger, Christian Müller, Fredrik Waneck, Michael Trauner, Claus Kölblinger, Arnulf Ferlitsch, Wolfgang Sieghart, Markus Peck-Radosavljevic, Matthias Pinter. Short‐ and long‐term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. United European Gastroenterology Journal 2019; 7(6): 850 doi: 10.1177/2050640619840199
|
| 18 |
Soumya Jogi, Radha Varanai, Sravani S. Bantu, Ashish Manne. Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines. Oncology Reviews 2020; 14(2) doi: 10.4081/oncol.2020.515
|